Company Overview
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Building Adhesive Solutions. The Hygiene, Health and Consumable Adhesives segment produces and supplies specialty industrial adhesives, such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven and hygiene, and medical and beauty. The Engineering Adhesives segment produces and supplies high performance industrial adhesives comprising reactive, light cure, two-part liquids, polyurethane, silicone, film, and fast cure products to the durable assembly, performance wood and textile, transportation, electronics, clean energy, aerospace and defense, appliance, heavy machinery, and insulating glass markets. The Construction Adhesives segment provides products used for commercial roofing, heating, ventilation, and air conditioning and insulation applications, as well as caulks and sealants for the consumer market and professional trade. The company sells its products directly to customers, as well as through distributors and retailers in North America, Latin America, Europe, India, the Middle East, Africa, and the Asia Pacific. H.B. Fuller Company was founded in 1887 and is headquartered in Saint Paul, Minnesota.
Why Investors Should Care
Net profit has compounded at 13.1% per year over the last five years.
Trades at a P/E of 19.7, below the sector median of 23.1.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Nov 2025 Revenue of $3.47B (-2.7% YoY); net profit $151.97M.
- Trailing 12 Months Year-on-year growth — revenue -2.3%, earnings +58.3%.
- 5-Year Trend Long-term compounding — revenue CAGR 5.5%, profit CAGR 13.1%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 5.53% |
| 1 Year: | -2.30% |
Compounded Profit Growth
| 5 Years: | 13.05% |
| 1 Year: | 58.30% |
Stock Price Performance
| 1 Year: | -7.04% |
| 6 Months: | -13.12% |
| 3 Months: | -9.11% |
| 1 Month: | -10.42% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)42.01 · Neutral
P/E of 19.72 is below the sector median of 23.08 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Profit CAGR of 13.1% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Basic Materials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | FUL H.B. Fuller Company R2K | 57.00 | 19.72 | $3.11B | 1.54% | 7.84% | 8.32% | 5.53% | 13.05% |
| 2 | LIN Linde plc NDXSPX | 514.15 | 34.05 | $237.72B | 1.22% | 12.46% | 18.23% | 13.90% | 18.47% |
| 3 | NEM Newmont Corporation SPX | 95.21 | 12.35 | $101.64B | 1.10% | - | 25.83% | 6.53% | 20.15% |
| 4 | FCX Freeport-McMoRan Inc. SPX | 60.97 | 32.26 | $87.65B | 0.97% | 12.50% | 15.63% | 1.35% | -1.26% |
| 5 | SHW The Sherwin-Williams Company SPX | 332.29 | 31.92 | $81.95B | 0.97% | 21.93% | 60.72% | 6.18% | 8.26% |
| 6 | ECL Ecolab Inc. SPX | 270.25 | 36.57 | $76.06B | 1.07% | 14.29% | 22.43% | 6.17% | 9.18% |
| 7 | CRH CRH plc SPX | 103.96 | 19.04 | $69.47B | 1.52% | 10.97% | 15.81% | 6.41% | 9.30% |
| 8 | APD Air Products and Chemicals, Inc. SPX | 293.69 | 30.98 | $65.40B | 2.40% | -0.62% | 12.35% | -1.77% | -39.16% |
| 9 | CTVA Corteva, Inc. SPX | 84.45 | 46.15 | $56.48B | 0.84% | - | 5.14% | 2.86% | 9.94% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Feb 2015 | May 2015 | Aug 2015 | Nov 2015 | Feb 2016 | May 2016 | Aug 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Aug 2019 | Nov 2019 | Feb 2020 | May 2020 | Aug 2020 | Nov 2020 | Feb 2021 | May 2021 | Aug 2021 | Feb 2022 | May 2022 | Aug 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Aug 2024 | Mar 2025 | May 2025 | Aug 2025 | Feb 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | 503.32M | 561.65M | 562.87M | 678.20M | 713.08M | 789.39M | 770.11M | 768.43M | 672.93M | 759.58M | 725.38M | 739.11M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 116.21M | 148.94M | 146.84M | 156.06M | 137.60M | 158.26M | 146.12M | 167.82M | 139.63M | 146.53M | 150.12M | 168.79M | 185.51M | 220.19M | 215.03M | 207.43M | 179.93M | 218.46M | 207.32M | 201.22M | 170.26M | 184.90M | 187.84M | 213.64M | 192.36M | 217.55M | 193.95M | 212.89M | 253.52M | 249.16M | 214.81M | 256.77M | 263.47M | 239.24M | 282.05M | 275.73M | 227.07M | 286.38M | 285.11M | 236.05M |
| Operating Income | 21.37M | 48.35M | 48.54M | - | 37.84M | 54.57M | 48.43M | - | 26.08M | 43.27M | 40.18M | - | 32.81M | 73.30M | 67.29M | - | 34.21M | 72.38M | 66.71M | - | 28.75M | 56.90M | 58.73M | - | 48.35M | 69.14M | 59.45M | 57.00M | 87.51M | 87.95M | 60.27M | 90.15M | 91.32M | 66.88M | 100.60M | 104.34M | 46.45M | 100.04M | 110.14M | - |
| Net Income | 9.71M | 25.17M | 26.81M | - | 18.92M | 33.33M | 32.74M | - | 14.79M | 25.87M | 25.14M | - | 47.68M | 44.45M | 37.73M | - | 12.24M | 36.64M | 49.72M | 32.21M | 9.89M | 31.61M | 41.61M | 40.60M | 29.79M | 49.10M | 31.62M | 38.31M | 47.20M | 46.50M | 21.89M | 40.40M | 37.63M | 30.99M | 51.26M | 55.36M | 13.25M | 41.83M | 67.16M | 21.05M |
| Diluted EPS | 0.19 | 0.49 | 0.52 | - | 0.37 | 0.65 | 0.64 | - | 0.29 | 0.50 | 0.49 | - | 0.92 | 0.86 | 0.72 | - | 0.24 | 0.70 | 0.97 | 0.61 | 0.19 | 0.61 | 0.79 | 0.77 | 0.56 | 0.90 | 0.58 | 0.69 | 0.86 | 0.84 | 0.39 | 0.73 | 0.67 | 0.55 | 0.91 | 0.98 | 0.24 | 0.76 | 1.22 | 0.38 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Nov 2008 | Nov 2009 | Nov 2010 | Dec 2011 | Dec 2012 | Nov 2013 | Nov 2014 | Nov 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Nov 2019 | Nov 2020 | Nov 2021 | Dec 2022 | Dec 2023 | Nov 2024 | Nov 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.39B | 1.23B | 1.26B | 1.44B | 1.89B | 2.05B | 2.10B | 2.08B | 2.09B | 2.31B | 3.04B | 2.90B | 2.79B | 3.28B | 3.75B | 3.51B | 3.57B | 3.47B |
| Gross Profit | 364.45M | 371.30M | 358.17M | 403.83M | 517.28M | 570.17M | 533.29M | 568.04M | 605.82M | 598.99M | 828.16M | 806.92M | 756.65M | 845.32M | 963.70M | 1.01B | 1.06B | 1.08B |
| Operating Income | 2.79M | 107.16M | 94.62M | 116.96M | 162.54M | 195.50M | 149.84M | 170.49M | 198.18M | 119.53M | 237.89M | 225.99M | 218.32M | 252.61M | 322.72M | 355.14M | 348.22M | - |
| Net Income | 18.89M | 83.65M | 70.88M | 89.11M | 125.62M | 96.76M | 49.77M | 86.68M | 121.66M | 59.42M | 171.21M | 130.82M | 123.72M | 161.39M | 180.31M | 144.91M | 130.26M | 151.97M |
| Diluted EPS | 0.36 | 1.70 | 1.43 | 1.79 | 2.48 | 1.89 | 0.97 | 1.69 | 2.37 | 1.15 | 3.29 | 2.52 | 2.36 | 2.97 | 3.26 | 2.59 | 2.30 | 2.75 |
| R&D Expense | - | 16.99M | 19.11M | 20.75M | 21.25M | 24.57M | 21.25M | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2007 | Nov 2008 | Nov 2009 | Nov 2010 | Dec 2011 | Dec 2012 | Nov 2013 | Nov 2014 | Nov 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Nov 2019 | Nov 2020 | Nov 2021 | Dec 2021 | Dec 2022 | Dec 2023 | Nov 2024 | Nov 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 1.10B | 1.15B | 1.23B | 1.79B | 1.87B | 1.87B | 2.04B | 2.06B | 4.37B | 4.18B | 3.99B | 4.04B | 4.27B | 4.27B | 4.46B | 4.72B | 4.93B | 5.18B |
| Total Equity | 802.05M | 538.45M | 591.35M | 631.93M | 705.20M | 778.27M | 930.07M | 890.05M | 872.92M | 937.88M | 1.05B | 1.15B | 1.22B | 1.38B | 1.60B | 1.60B | 1.61B | 1.76B | 1.83B | 2.00B |
| Cash & Equivalents | 246.36M | 80.37M | 98.65M | 154.65M | 154.65M | 200.44M | 155.12M | 77.57M | 119.17M | 142.25M | 194.40M | 150.79M | 112.19M | 100.53M | 61.79M | 61.79M | 79.91M | 179.45M | 169.35M | 107.21M |
| Long Term Debt | - | - | - | 200.98M | 179.61M | 475.11M | 472.31M | 547.74M | 669.61M | 585.76M | 2.40B | 2.14B | 1.90B | 1.76B | 1.59B | 1.59B | 1.74B | 1.84B | 2.01B | 2.02B |
| Total Liabilities | - | - | 506.20M | 519.07M | 518.25M | 1.00B | 937.85M | 973.90M | 1.16B | 1.11B | 3.32B | 3.02B | 2.76B | 2.65B | 2.68B | 2.68B | 2.85B | 2.97B | 3.10B | 3.18B |
| Current Liabilities | - | - | 236.01M | 231.33M | 254.99M | 350.12M | 360.78M | 317.20M | 349.52M | 391.84M | 504.91M | 546.12M | 542.16M | 530.13M | 736.85M | 736.85M | 705.73M | 692.81M | 719.29M | 743.36M |
Cash Flows (Annual)
Figures in USD.
| Metric | Nov 2008 | Nov 2009 | Nov 2010 | Dec 2011 | Dec 2012 | Nov 2013 | Nov 2014 | Nov 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Nov 2019 | Nov 2020 | Nov 2021 | Dec 2022 | Dec 2023 | Nov 2024 | Nov 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - | - | - | 195.69M | 166.32M | 253.31M | 269.18M | 331.56M | 213.32M | 256.51M | 378.40M | 302.44M | 263.49M |
| Investing Cash Flow | - | - | - | - | - | - | - | - | -111.53M | -1.80B | -61.84M | 7.41M | -109.46M | -94.66M | -375.29M | -319.20M | -407.08M | -232.25M |
| Financing Cash Flow | - | - | - | - | - | - | - | - | -52.59M | 1.68B | -228.60M | -315.05M | -239.21M | -154.07M | 160.32M | 35.14M | 112.09M | -107.90M |
| Capital Expenditure | -19.96M | -22.74M | -31.73M | -32.83M | -35.91M | -124.29M | -139.79M | -58.62M | -63.31M | -54.93M | -68.26M | -61.98M | -87.29M | -96.09M | -129.96M | -119.14M | -139.24M | -142.28M |
| Free Cash Flow | - | - | - | - | - | - | - | - | 132.38M | 111.39M | 185.05M | 207.19M | 244.27M | 117.23M | 126.55M | 259.26M | 163.20M | 121.22M |
| Share Buybacks | 200.75M | 362.00K | 377.00K | 8.51M | 4.33M | 17.64M | 15.51M | 19.29M | 23.23M | 21.83M | 4.69M | 3.03M | 3.43M | 2.68M | 3.95M | 2.57M | 39.56M | 60.71M |
Ratios (Annual)
Figures in %.
| Metric | Nov 2008 | Nov 2009 | Nov 2010 | Dec 2011 | Dec 2012 | Nov 2013 | Nov 2014 | Nov 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Nov 2019 | Nov 2020 | Nov 2021 | Dec 2022 | Dec 2023 | Nov 2024 | Nov 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 26.2% | 30.1% | 28.5% | 28.0% | 27.4% | 27.9% | 25.3% | 27.3% | 28.9% | 26.0% | 27.2% | 27.9% | 27.1% | 25.8% | 25.7% | 28.7% | 29.8% | 31.1% |
| Operating Margin % | 0.2% | 8.7% | 7.5% | 8.1% | 8.6% | 9.6% | 7.1% | 8.2% | 9.5% | 5.2% | 7.8% | 7.8% | 7.8% | 7.7% | 8.6% | 10.1% | 9.8% | - |
| Net Margin % | 1.4% | 6.8% | 5.6% | 6.2% | 6.7% | 4.7% | 2.4% | 4.2% | 5.8% | 2.6% | 5.6% | 4.5% | 4.4% | 4.9% | 4.8% | 4.1% | 3.6% | 4.4% |
| ROE % | 3.5% | 14.1% | 11.2% | 12.6% | 16.1% | 10.4% | 5.6% | 9.9% | 13.0% | 5.7% | 14.9% | 10.7% | 9.0% | 10.1% | 11.2% | 8.3% | 7.1% | 7.6% |
| ROCE % | - | 12.4% | 10.3% | 12.0% | 11.3% | 12.9% | 9.7% | 10.1% | 11.9% | 3.1% | 6.6% | 6.6% | 6.2% | 7.1% | 8.6% | 8.8% | 8.3% | - |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 14.93% | 8.03M | $449.87M |
| 2 | Vanguard Portfolio Management LLC | 6.97% | 3.75M | $209.97M |
| 3 | State Street Corporation | 5.12% | 2.76M | $154.40M |
| 4 | Dimensional Fund Advisors LP | 4.85% | 2.61M | $146.10M |
| 5 | Capital World Investors | 4.82% | 2.59M | $145.29M |
| 6 | Vanguard Capital Management LLC | 4.52% | 2.43M | $136.17M |
| 7 | Mairs & Power Inc | 4.39% | 2.36M | $132.30M |
| 8 | Kayne Anderson Rudnick Investment Management LLC | 3.87% | 2.08M | $116.46M |
| 9 | Cooke & Bieler LP | 2.91% | 1.56M | $87.56M |
| 10 | UBS Group AG | 2.68% | 1.44M | $80.76M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for FUL
Should Value Investors Buy H. B. Fuller (FUL) Stock? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOYlpOYmkxOGJvQVBha1R2ZFRWZE5rOElYRk8xd0VMOVA5UjVLRUpnQm4tWExsRUNxeEQ1WHRWeXhfYk81SlhBUWxob0xkZWF6Uk4tU2hGVDItMFUtSGJoVlVOdEc5ZG5Ya2YwcGNrbWVXb0VYZXZwR1BDX2x0dDZ4VmNQOFZfdzg3ajNlel…
Is FUL Stock a Buy Now or a Value Trap for Cautious Investors? - TradingView
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxQaXRad1FfTlNoUVV4bWpHX2NSUHVzeWhLYjRFTGtfRG5jSFJxdy1jTzFZeXFRbjIyajdPdUI2bGpJaWV4ZXRra2djdjItekNZMUJZOW9kR2FTVGROMTBDY2t0cHpIZFFKTm8yYzRpWTFOcW1EQ3RWREp0MnZuOTRXb251Q040by1ucmxrOF…
FUL Stock Is Riding Medical, Aerospace and Pricing Trends - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxOMC10MXhMMWUzVHFNQ0RtMnFyT2p6Sy1FZjVYVXNraklfOFdza0lIOHV5X0xIV1pHbE5SLWhXQnRWS2R1OW8yc1pnTk9lS2xBV1NHdjFPc29WaWpxMEk0QU1Bdk1MMFpwZzBWZ25EYkE4ZGd6WE1ROEU0N0NXMHZDeThQSmlSLVQ0TmItLU…
Is FUL Stock a Buy Now or a Value Trap for Cautious Investors? - Zacks Investment Research
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxOUUc3WUxKY05XaVJsZW0zUGVaNGViazFIdmhXcFktNmdaUDBiamM0aW5abks2YXJ4Q0w3bmNXZjZ5NDdXbWtucEVlSGNXX292YlhCcVdHMDJBZ3hlSU1lTVdLeENZWmJIbDJwMmVwYjl6MkswNlVNbVUyRGxvLWxBX3VkVXVScjNvOVFicm…
H.B. Fuller Sees $55M Synergy Potential From AMS Deal – But Investors Are Still Selling FUL Stock - Stocktwits
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxQYUJ1RTZURTBlUTYyTHNYNHhHdTVQWmF3RFNyVGdWRkR5Vk1sSGdMUGlIc3FRRXI0UVhMVFZUWURtSU1VSy15XzhZb1FjTFFUZFN0RS0zV1pXNVNaWUIxQzNhaHBsdmsyanhHZ0FsejFKa3hvY2MxZjJrNWFGVEtGek0wMW1EeWpGbkRPVW…
Stocks to watch on Wednesday after hours: MU, FUL, and JEF - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxOOWN0aHI3X0dxbGo3Y0twYUh5cUpESkVoQUItVmFGSjdaVXltdWZJOUxnVl9fU25TZDltNVRpLWhjbW1FZ3diSmFEeHltZWV6RFNKUnhuQWFzX0tzLVdtT3NSTW9ncU5IMEVkc2ZzRU5pb1p1Zks0ZW1uUV8tWTBNZmhoWG5NUHhLcl9MTU…
FUL — Frequently Asked Questions
What is the current share price of H.B. Fuller Company (FUL)?
As of 2026-07-15 16:51 PDT, H.B. Fuller Company (FUL) trades at $57.00 on NYSE. Its 52-week range is $49.09 to $67.21.
What is the market capitalisation of FUL?
H.B. Fuller Company (FUL) has a market capitalisation of $3.11B on NYSE.
What is the P/E ratio of FUL?
FUL trades at a trailing price-to-earnings (P/E) ratio of 19.72. The industry average P/E is 23.08. Its price-to-book (P/B) ratio is 1.68.
Does FUL pay a dividend?
H.B. Fuller Company (FUL) currently offers a dividend yield of 1.54%.
What is the return on equity (ROE) of FUL?
FUL has a return on equity (ROE) of 8.32%. Its return on capital employed (ROCE) is 7.84%.
Is FUL a good stock to buy?
This page provides a data-driven analysis of H.B. Fuller Company (FUL), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.